Puma Biotechnology, Inc. (PBYI)
10.22
+0.39
(+3.97%)
USD |
NASDAQ |
Oct 19, 16:00
10.22
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Market Cap : 522.27M for Oct. 19, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 502.34M |
| October 15, 2026 | 537.60M |
| October 14, 2026 | 521.25M |
| October 13, 2026 | 517.16M |
| October 12, 2026 | 525.85M |
| October 09, 2026 | 525.85M |
| October 08, 2026 | 509.49M |
| October 07, 2026 | 501.32M |
| October 06, 2026 | 485.48M |
| October 05, 2026 | 494.16M |
| October 02, 2026 | 485.99M |
| October 01, 2026 | 502.85M |
| September 30, 2026 | 507.45M |
| September 29, 2026 | 499.78M |
| September 28, 2026 | 501.83M |
| September 25, 2026 | 499.27M |
| September 24, 2026 | 501.83M |
| September 23, 2026 | 474.23M |
| September 22, 2026 | 501.83M |
| September 21, 2026 | 490.07M |
| September 18, 2026 | 490.59M |
| September 17, 2026 | 486.50M |
| September 16, 2026 | 479.85M |
| September 15, 2026 | 472.70M |
| September 14, 2026 | 467.08M |
| Date | Value |
|---|---|
| September 11, 2026 | 466.06M |
| September 10, 2026 | 468.61M |
| September 09, 2026 | 462.48M |
| September 08, 2026 | 479.85M |
| September 04, 2026 | 488.03M |
| September 03, 2026 | 480.88M |
| September 02, 2026 | 495.19M |
| September 01, 2026 | 477.81M |
| August 31, 2026 | 465.55M |
| August 28, 2026 | 462.99M |
| August 27, 2026 | 472.19M |
| August 26, 2026 | 468.10M |
| August 25, 2026 | 476.28M |
| August 24, 2026 | 466.06M |
| August 21, 2026 | 472.19M |
| August 20, 2026 | 465.55M |
| August 19, 2026 | 484.96M |
| August 18, 2026 | 472.19M |
| August 17, 2026 | 450.73M |
| August 14, 2026 | 451.24M |
| August 13, 2026 | 445.10M |
| August 12, 2026 | 454.81M |
| August 11, 2026 | 448.17M |
| August 10, 2026 | 444.08M |
| August 07, 2026 | 455.33M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 270.87M |
| Arcutis Biotherapeutics, Inc. | 4.009B |
| Olema Pharmaceuticals, Inc. | 622.66M |
| ACADIA Pharmaceuticals, Inc. | 3.410B |
| Alnylam Pharmaceuticals, Inc. | 31.21B |
Market Cap Related Metrics
| PE Ratio | 19.79 |
| PS Ratio | 2.275 |
| Price to Book Value | 3.770 |
| Price to Free Cash Flow | 12.78 |
| Price | 10.22 |
| Earnings Yield | 5.05% |
| Operating PE Ratio | 17.28 |
| Normalized PE Ratio | 19.79 |